is zepbound same as mounjaro

Zacks Investment Research on MSN: How will Mounjaro and Zepbound sales aid LLY's upcoming Q1 results? Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its blockbuster GLP-1 therapies, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Healthline: Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so dramatically that people are spending noticeably less on groceries.

Understanding the Context

But one ... Eli Lilly and Co. reported fourth-quarter results Wednesday that topped Wall Street expectations, with revenue of $19.3 billion — up 43% from the same quarter a year ago, driven by growth in sales of ... Share on Pinterest Tirzepatide may help lower the risk of diabetic retinopathy, a diabetes complication that can lead to vision loss.